U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07288983) titled 'PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery' on Dec. 04... Read More
U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07289204) titled 'FinnDiane LifeOne Study - Impact of Ageing on People With Type 1 Diabetes' on Dec. 03. Bri... Read More
U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07287644) titled 'A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa' on Nov. 13. Brie... Read More
U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07288515) titled 'Observ Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in Belarus' on... Read More
U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07287917) titled 'Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors... Read More
U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07288307) titled 'Surgical Evacuation Versus Methotrexate Injection in Treatment of Caesarean Scar Pregnancy ... Read More
U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07290036) titled 'A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Through... Read More
U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07289932) titled '"Clinical Evaluation of Self-Assembling Peptides Versus Tri-Calcium Phosphate Based Varnish... Read More
U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07288398) titled 'LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2' on Dec. 1... Read More
U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07287397) titled 'Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS' on Nov.... Read More